Cerebras Raises IPO Target to 55 Billion Eyes 40 Billion Valuation Amid AI Chip Frenzy Weekend Work Patterns in Europe Balkan and Mediterranean Employees Lead FourDay Week Trials Gain Momentum Janux Therapeutics JANX Slips 055 Testing 1380 Support 20260514